Experiments to reduce obesity with diabetes medicine successful
Chicago: A global team of experts has succeeded in human trials to reduce obesity with a diabetes drug.
The trials lasted for 68 weeks on 1961 obese volunteers. Although all of these people were obese, none of them had diabetes.
During the study, about half of the volunteers were injected with only 2.4 mg of the drug semaglutide once a week. This diabetes medicine is sold under the name ‘Ozempic’.
The remaining half of the volunteers were injected with another harmless solution called placebo.
All of the volunteers who took part in the medical trials, which lasted for almost two years, followed medication as well as healthy lifestyle.
At the end of the study, it was found that the volunteers once a week